OPRX

SEC source: 0001628280-24-034830 · wk-form4_1722892955.xml · derivative · entry 1

McCarthy Brian Clark · CIK 0002031237 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,677

Underlying: Common Stock · 18,677 shares

Expires 2027-08-02

F1 · derivative.exercise_date: The Stock Option will vest 1/3 at the end of each anniversary from issuance.

SEC source: 0001628280-24-027710 · wk-form4_1718142449.xml · nonDerivative · entry 1

KLEMA CATHY · CIK 0001181157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,643

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027716 · wk-form4_1718142621.xml · nonDerivative · entry 2

Spangler Patrick D · CIK 0001296525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,467

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · nonDerivative · entry 2

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,774

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027714 · wk-form4_1718142520.xml · nonDerivative · entry 2

WASSON GREGORY D · CIK 0001188827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,315

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027709 · wk-form4_1718142412.xml · nonDerivative · entry 2

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,044

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

SEC source: 0001628280-24-027716 · wk-form4_1718142621.xml · derivative · entry 3

Spangler Patrick D · CIK 0001296525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F3 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027716 · wk-form4_1718142621.xml · nonDerivative · entry 1

Spangler Patrick D · CIK 0001296525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · derivative · entry 3

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F3 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027715 · wk-form4_1718142583.xml · nonDerivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-027714 · wk-form4_1718142520.xml · derivative · entry 3

WASSON GREGORY D · CIK 0001188827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F3 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027714 · wk-form4_1718142520.xml · nonDerivative · entry 1

WASSON GREGORY D · CIK 0001188827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-027712 · wk-form4_1718142490.xml · derivative · entry 2

HALAS GUS D · CIK 0001230322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F2 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027712 · wk-form4_1718142490.xml · nonDerivative · entry 1

HALAS GUS D · CIK 0001230322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-027709 · wk-form4_1718142412.xml · derivative · entry 3

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,061 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis

F3 · derivative.exercise_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

F3 · derivative.expiration_date: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.

SEC source: 0001628280-24-027709 · wk-form4_1718142412.xml · nonDerivative · entry 1

Lang James Paul · CIK 0001703090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,758

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis

SEC source: 0001628280-24-020821 · wk-form4_1715045740.xml · derivative · entry 3

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,000 shares

Expires 2024-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F3 · derivative.exercise_date: The restricted stock units cliff vested in full on May 2, 2024, the fifth anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units cliff vested in full on May 2, 2024, the fifth anniversary of the grant date.

SEC source: 0001628280-24-020821 · wk-form4_1715045740.xml · nonDerivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,846

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-020821 · wk-form4_1715045740.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

SEC source: 0001628280-24-027755 · wk-form4_1718206887.xml · derivative · entry 3

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,790

Underlying: Common · 28,895 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-24-027755 · wk-form4_1718206887.xml · nonDerivative · entry 2

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 581,253

F3 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-027755 · wk-form4_1718206887.xml · nonDerivative · entry 1

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 582,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · balance_after: The Reporting Person's prior holdings were previously inadvertently overstated by four shares.

SEC source: 0001628280-24-016621 · wk-form4_1713388959.xml · nonDerivative · entry 1

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 538,144

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on April 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-017545 · wk-form4_1713967450.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,706

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-009405 · wk-form4_1709759929.xml · derivative · entry 3

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 771

Underlying: Common Stock · 771 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

SEC source: 0001628280-24-009405 · wk-form4_1709759929.xml · nonDerivative · entry 2

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,231

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-009405 · wk-form4_1709759929.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-009407 · wk-form4_1709760003.xml · derivative · entry 3

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,928

Underlying: Common Stock · 1,927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

SEC source: 0001628280-24-009407 · wk-form4_1709760003.xml · nonDerivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,956

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-009407 · wk-form4_1709760003.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

SEC source: 0001628280-24-020819 · wk-form4a_1715045619.xml · nonDerivative · entry 2

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,261

F3 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. The original Form 4 filed by the Reporting Person reporting this transaction overstated the number of shares withheld by the Issuer.

SEC source: 0001628280-24-020819 · wk-form4a_1715045619.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2 · balance_after: A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.

SEC source: 0001628280-24-017551 · wk-form4_1713968321.xml · nonDerivative · entry 1

Besch Doug · CIK 0001947731 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,848

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-017550 · wk-form4_1713968255.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,498

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-017549 · wk-form4_1713968169.xml · nonDerivative · entry 1

Stelmakh Edward · CIK 0001887046 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,765

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-017552 · wk-form4_1713968401.xml · nonDerivative · entry 1

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 553,144

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

SEC source: 0001628280-24-020817 · wk-form4a_1715045531.xml · nonDerivative · entry 1

Silvestro Stephen L · CIK 0001773461 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,906

F1 · date: This Form 4 as originally filed reported in Table 1 a grant of Common Stock on March 15, 2024. However, this transaction occurred on February 15, 2024.

F2 · shares: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

F3 · balance_after: A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.

SEC source: 0001628280-24-052517 · wk-form4a_1735335531.xml · nonDerivative · entry 1

Stelmakh Edward · CIK 0001887046 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,365

F1 · balance_after: On April 24, 2024, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently understated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent understatement has been corrected in this amended filing. This understatement also affected the holdings reported in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing.

SEC source: 0001628280-24-004575 · wk-form4_1707866168.xml · derivative · entry 3

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-24-004575 · wk-form4_1707866168.xml · nonDerivative · entry 2

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,728

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-004575 · wk-form4_1707866168.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-003584 · wk-form4_1707267174.xml · derivative · entry 1

KLEMA CATHY · CIK 0001181157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,109

Underlying: Common Stock · 5,109 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2 · derivative.exercise_date: The restricted stock units will vest in full on the first anniversary of the date of grant.

F2 · derivative.expiration_date: The restricted stock units will vest in full on the first anniversary of the date of grant.

SEC source: 0001628280-24-001190 · wk-form4_1705010757.xml · nonDerivative · entry 1

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,114

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.41. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001628280-24-001718 · wk-form4_1705618557.xml · derivative · entry 3

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,628 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-24-001718 · wk-form4_1705618557.xml · nonDerivative · entry 2

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 478,144

F2 · shares: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001628280-24-001718 · wk-form4_1705618557.xml · nonDerivative · entry 1

FEBBO WILLIAM J · CIK 0001413987 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001628280-24-006021 · wk-form4_1708557934.xml · derivative · entry 2

Besch Doug · CIK 0001947731 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,892

Underlying: Common Stock · 5,892 shares

Expires 2026-12-19

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

SEC source: 0001628280-24-006021 · wk-form4_1708557934.xml · derivative · entry 1

Besch Doug · CIK 0001947731 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,892

Underlying: Common Stock · 5,892 shares

Expires 2026-12-19

F1 · derivative.exercise_date: The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

SEC source: 0001628280-24-006019 · wk-form4_1708557790.xml · derivative · entry 2

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,783

Underlying: Common Stock · 11,783 shares

Expires 2026-12-19

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning October 19, 2024, the first anniversary of the grant date.

SEC source: 0001628280-24-006019 · wk-form4_1708557790.xml · derivative · entry 1

Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,783

Underlying: Common Stock · 11,783 shares

Expires 2026-12-19

F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning October 19, 2024, the first anniversary of the grant date.